...
机译:基于烯丙基酪氨酸的三肽作为HIV-1整合酶链转移反应的选择性抑制剂的发现
School of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia;
School of Science and Health, Western Sydney University, Locked Bag 1797, Penrith South DC, Australia,School of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia;
School of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia;
Genera Biosystems, Scoresby, Vic 3179, Australia,Avexa Ltd, 576 Swan St, Richmond, Vic 3121, Australia;
Avexa Ltd, 576 Swan St, Richmond, Vic 3121, Australia;
Monash Institute of Materials Engineering, Monash University, Clayton, Vic 3800, Australia,Avexa Ltd, 576 Swan St, Richmond, Vic 3121, Australia;
Avexa Ltd, 576 Swan St, Richmond, Vic 3121, Australia;
School of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia;
School of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia;
School of Chemistry, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia;
机译:活性位点中关键的酶-DNA相互作用决定了3'加工过程中链转移的选择性以及对HIV-1整合酶抑制剂临床耐药性的敏感性。
机译:在活性位点中关键的酶,DNA,DNA相互作用决定了在3′→2′-加工过程中链转移的选择性和对HIV-1整合酶抑制剂临床抵抗的敏感性。
机译:HIV-1整合酶链转移抑制剂的基于药理学设计
机译:改进HIV-1整合酶抑制剂发现线性模型的特征选择
机译:设计和发现抑制细胞LEDGF / p75和HIV-1整合酶相互作用的小分子。
机译:在活性位点中关键的酶-DNA相互作用决定了3加工过程中链转移的选择性以及对HIV-1整合酶抑制剂临床耐药性的敏感性。
机译:基于烯丙基酪氨酸的三肽作为HIV-1整合酶链转移反应的选择性抑制剂的发现